A

Amphastar Pharmaceuticals
D

AMPH

24.570
USD
-0.76
(-3.00%)
مغلق
حجم التداول
11,870
الربح لكل سهم
0
العائد الربحي
-
P/E
9
حجم السوق
1,158,207,318
أصول ذات صلة
A
ASND
6.170
(3.62%)
176.650 USD
BIIB
BIIB
0.480
(0.38%)
127.050 USD
GILD
GILD
-0.020
(-0.02%)
108.000 USD
I
INO
0.01500
(0.77%)
1.95500 USD
I
IONS
0.410
(1.11%)
37.420 USD
REGN
REGN
-3.73
(-0.73%)
509.70 USD
S
SRPT
-0.660
(-3.18%)
20.100 USD
VRTX
VRTX
-7.64
(-1.70%)
440.97 USD
المزيد
الأخبار المقالات

العنوان: Amphastar Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulinactive pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.